SCOPE International, an independent global, full-service contract research organization (CRO) headquartered in Mannheim, Germany, has opened its 17th international office for business in Pittsburgh, Pennsylvania on Monday, October 12. With over 15 years of experience in supporting clinical trials and regulatory submissions for pharmaceutical, biotechnology, and medical device companies, SCOPE offers comprehensive clinical development services, including project management, clinical monitoring, data management, biostatistics, and medical writing for a single trial or an entire clinical trials program. The company also offers consulting and on-demand solutions.
"The expansion into the US represents our commitment towards our continued growth through strengthened operational capabilities. We are dedicated to maintaining and augmenting our competencies and expertise across the US and Canada in order to address the diverse needs of our clients," says Gerald Meub, CEO of the headquarters office.
SCOPE is the first global, full-service CRO that has selected Pittsburgh, a city known to have both an emerging start-up and established life science sector, for its US office and North American operations, and appointed Alethea Wieland as the US office President and CEO to lead business development and operations. Ms. Wieland previously held various regulatory and clinical leadership positions at the National Surgical Adjuvant Breast and Bowel Project (NSABP Foundation Inc.), and start-ups CECity, Inc., Helomics (formerly Precision Therapeutics, Inc.), and ALung Technologies, Inc.
"Pittsburgh and similar prestigious academic centers in close proximity to this region, such as Cleveland, Buffalo, and Rochester are poised with numerous possibilities for continued economic growth in the life sciences," suggests Wieland, "and with a highly educated workforce in a cost-effective part of the country, we believe our unique employment and financial models will be considerable benefits to our clients."
The US office opens with multiple projects underway and more slated for 2016.
"Congratulations to SCOPE International on the opening of its 17th international office," says Suzi Pegg, Vice President of Pittsburgh Regional Alliance. "The company's portfolio of services, ranging from support for early development of clinical products through marketing authorization, and post-market solutions, is a great addition to our life sciences community, and we believe that Pittsburgh is the best place for SCOPE to continue to grow its business."
A public open house is scheduled for early winter.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151014006647/en/
Contacts:
SCOPE International USA, Inc.
Alethea Wieland, President and CEO (North American Operations)
+1-724-272-1245
awieland@scope-international.com
http://www.scope-international.com
